Markers of endothelial dysfunction in pregnant after flu during pregnancy: performance and prognostic significance

10.12737/7374 ◽  
2014 ◽  
Vol 8 (1) ◽  
pp. 0-0
Author(s):  
Калиматова ◽  
D. Kalimatova ◽  
Шатунова ◽  
E. Shatunova
Keyword(s):  
Endothelial Dysfunction ◽  
Pregnant Women ◽  
Prognostic Significance ◽  
Perinatal Outcomes ◽  
Correlation Coefficients ◽  
Control Group ◽  
Endothelial Protein C Receptor ◽  
Definition Of ◽  
Somatic Diseases ◽  
Endothelial Growth Factor

It was performed the study of endothelial dysfunction markers dynamics in pregnant with influenza and evaluation of the prognostic significance of these parameters. It analyzed the data 44 included pregnant women (average age of 28,2±7,3 years) diagnosed with flu mean (n=26) and severe (n=18) degrees. 22 pregnant women with no evidence of infectious and somatic diseases in the control group (mean age 27,2±5,4 years). The diagnosis of highly pathogenic H1N1 was confirmed using virological examination, all patients were hospitalized. Found that pregnant women who have had the flu during gestation, it reveals significant shifts of the levels of markers of endothelial dysfunction in blood plasma: reducing the concentration of vascular endothelial growth factor (VEGF) reduced compared with healthy pregnant women and increased levels of endothelial protein C receptor along with increasing concentrations endothelin-1. It is shown that with increasing severity of flu during pregnancy, the severity of the imbalance of these markers is increased. The presence of significant correlation coefficients significant moderate force between the frequency of complications of pregnancy, childbirth and perinatal outcomes and degree of changes in the concentrations of markers of endothelial dysfunction. It is concluded that high prognostic value of assessing these factors, it is proposed to include them in the definition of an algorithm for pregnant women with influenza.

Improving medical-diagnostic actions of the flu during pregnancy

10.12737/8626 ◽  
2015 ◽  
Vol 9 (1) ◽  
pp. 0-0
Author(s):  
Шатунова ◽  
E. Shatunova ◽  
Калиматова ◽  
D. Kalimatova ◽  
Лимарева ◽  
...  
Keyword(s):  
Endothelial Dysfunction ◽  
Pregnant Women ◽  
Perinatal Outcomes ◽  
Correlation Coefficients ◽  
Respiratory Illness ◽  
Premature Delivery ◽  
Pregnancy And Childbirth ◽  
Medical Diagnostic ◽  
Vascular Endothelial Factor ◽  
Definition Of

Surveyed 202 pregnant women with a diagnosis of influenza medium (n=154) and severe (n=48) severity. An algorithm for management of pregnant women with influenza, which is monitoring the level of markers of endothelial dysfunction; it is shown that its use in clinical practice can reduce the frequency of complications of pregnancy and childbirth and to improve perinatal outcomes. The results were statistically evaluate the relationship between indicators of pregnancy and childbirth, and the dynamics of the concentrations of markers of endothelial dysfunction has revealed the presence of stable relationships indicators (statistically significant correlation coefficients Spearman moderate strength). In particular, it is shown that the vascular endothelial factor concentration is negatively associated with the incidence of intrauterine growth retardation, preeclampsia, placental insufficiency, anemia and threatened premature delivery, polyhydramnios. The results of the study, indicating the high prognostic value of the levels of markers of endothelial dysfunction, allow us to propose the inclusion of estimates of these parameters in the algorithm of management of pregnant women with influenza for the timely appointment of preventive and diagnostic and treatment activities in order to reduce the frequency of complications of pregnancy and childbirth and improve perinatal outcomes. The obtained results allow to conclude that pregnant women with symptoms of ARI (influenza) shows the definition of the levels of markers of endothelial dysfunction, a survey is recommended during the first indications of the disease. It is reasonable assessment of markers of endothelial dysfunction in this category pregnant in the dynamics after 1-2 months after acute respiratory illness.

Influence of Arterial Hypertension on the Pregnancy in Women with RH-Negative Blood

2015 ◽  
Vol 22 (3) ◽  
pp. 56-62
Author(s):  
Тамазаева ◽  
Kh. Tamazaeva ◽  
Омаров ◽  
N.S. Omarov
Keyword(s):  
Arterial Hypertension ◽  
Pregnant Women ◽  
High Titer ◽  
Perinatal Outcomes ◽  
Control Group ◽  
Threatened Premature Birth ◽  
Definition Of ◽  
D Antigen ◽  
Work Up

The purpose of the study was to assess the role of arterial hypertension (AH) in the development of immunization in women with Rh-negative blood to optimize perinatal outcomes. Subject and methods. A prospective comparatively study was conducted in 3 groups of pregnant women with Rh-negative blood. The 1-st group (n=148) was with hypertensive disease (HD), the 2-nd group (n=144) - with gestational arterial hypertension (GAH); the 3-rd group (n=110) - without somatic pathology. The immune-hematological studies included a definition of the partial D antigen using gel method. Results. It was definited that the pregnancy of these patients accompanied by the high frequency of early gestational toxicosis, threatened premature birth, preeclampsia, placental insufficiency as well as expressed changes immu-nological properties of blood, which are pathogenetic basis of fetal and neonatal rhesus hemolytic disease. Antibodies (AB) in the blood serum of patients with hypertension were detected in the first half of pregnancy (up to 20 weeks) in 1.2-1.4 times more often than in healthy women, high titer of AB rate in patients with HD was significantly higher compared to other groups. Disadvantageous combination of immunoglobulins subclasses Gl and G3 was found in the group of pregnant women with HD (11.4%) and GAH (10,8%), significantly less frequently (6,45%) in the control group. Conclusion. To improve maternal, fetal and neonatal gestation outcomes the authors justified the necessity of prenatal work-up and delivery of these women.

INOVASIA Study: A Randomized Open Controlled Trial to Evaluate Pravastatin to Prevent Preeclampsia and its Effects on sFlt1/PLGF Levels

2021 ◽  
Author(s):  
Muhammad Ilham Aldika Akbar ◽  
Angelina Yosediputra ◽  
Raditya Eri Pratama ◽  
Nur Lailatul Fadhilah ◽  
Sulistyowati Sulistyowati ◽  
...  
Keyword(s):  
High Risk ◽  
Pregnant Women ◽  
Controlled Trial ◽  
Intervention Group ◽  
Perinatal Outcomes ◽  
Neonatal Morbidity ◽  
Clinical Risk Factor ◽  
Control Group ◽  
Significant Deterioration ◽  
Plgf Ratio

Objectives To evaluate the effect of pravastatin to prevent preeclampsia (PE) in pregnant women at a high risk of developing preeclampsia and the maternal and perinatal outcomes and the sFlt1/PLGF ratio. Study Design This is an open labelled RCT part of INOVASIA trial. Pregnant women at a high risk of developing PE were recruited and randomized into an intervention group (40) and a control group (40). The inclusion criteria consisted of pregnant women with positive clinical risk factor and abnormal uterine artery doppler examination at 10-20 weeks gestational age. The control group received low dose aspirin (80 mg/day) and calcium (1 g/day), while the intervention group received additional pravastatin (20 mg twice daily) starting from 14-20 weeks gestation until delivery. Research blood samples were collected before the first dose of pravastatin and before delivery. The main outcome was the rate of maternal preeclampsia, maternal-perinatal outcomes, and sFlt-1, PLGF, sFlt-1/PlGF ratio and sEng levels. Results The rate of preeclampsia was (non-significantly) lower in the pravastatin group compared with the control group (17.5% vs 35%). The pravastatin group also had a (non-significant) lower rate of severe preeclampsia, HELLP syndrome, acute kidney injury and severe hypertension. The rate of (iatrogenic) preterm delivery was significantly (p=0.048) lower in the pravastatin group (n=4) compared with the controls (n=12). Neonates in the pravastatin group had significantly higher birthweights (2931 + 537 vs 2625 + 872 g; p=0.006), lower Apgar scores < 7 (2.5 vs 27.5%, p=0.002), composite neonatal morbidity (0 vs 20%, p=0.005) and NICU admission rates (0 vs 15%, p=0.026). All biomarkers show a significant deterioration in the control group compared with non significant changes in the pravastatin group. Conclusions Pravastatin holds promise in the secondary prevention of preeclampsia and placenta-mediated adverse perinatal outcomes by improving the angiogenic imbalance.

scholarly journals Effect of Serum Copper on Circulating Angiogenesis-Related Factors in Women with Preeclampsia

2019 ◽  
Author(s):  
Khalid Najm Nadheer ◽  
Zohreh Zahraei ◽  
Hussein Al-Hakeim
Keyword(s):  
Pregnant Women ◽  
Serum Copper ◽  
Control Group ◽  
Vascular Endothelial ◽  
Related Factors ◽  
Soluble Endoglin ◽  
Iraqi Women ◽  
Endothelial Integrity ◽  
And Control ◽  
Endothelial Growth Factor

Preeclampsia (PE) is characterized by a series of clinical features such as hypertension and proteinuria associated with endothelial dysfunction and the impairment of placenta vascular endothelial integrity. This study aimed to investigate the effect of serum copper (Cu) level on some angiogenesis-related factors including vascular endothelial growth factor-A (VEGF-A), soluble Fms-like tyrosine kinase-1 (sVEGF-R1), soluble endoglin (sEng) and cerruloplasmin (Cp) in Iraqi women with preeclampsia (PE) and control pregnant women. Therefore, 60 women with PE in addition to 30 healthy pregnant women were enrolled in the study. Serum concentration of sEng, VEGF-A, sVEGF-R1, and Cu in PE group significantly increased (p&lt;0.05) in the PE group compared with that in the control group. Increased production of antiangiogenic factors, soluble VEGF-A and sEng contribute to the pathophysiology of PE, indicating the involvement of these parameters in the angiogenic balance in patients with PE. Tests for between-subject effects showed that the circulating angiogenesis factors and Cu were significantly associated with the presence of PE. Serum Cu level was significantly correlated with VEGF- A and VEGF-R1 levels but not with sEng. Multiple regression analysis revealed that only Cp and BP can significantly predict the complications in women with PE. In conclusion, serum Cu has a role in the angiogenesis in women with PE and may be a new drug target in the prevention or treatment of PE.

Matrix metalloproteinases MMP-2 and MMP-9 as markers for the prediction of preeclampsia in the first trimester

2021 ◽  
Vol 86 (4) ◽  
pp. 228-235
Author(s):  
Elena Timokhina ◽  
◽  
Vadim Zinin ◽  
Irina Ignatko ◽  
Sapyat Ibragimova ◽  
...  
Keyword(s):  
Matrix Metalloproteinases ◽  
Matrix Metalloproteinase ◽  
Pregnant Women ◽  
Prognostic Significance ◽  
Subsequent Development ◽  
First Trimester ◽  
Control Group ◽  
Early Markers ◽  
Threatening Condition ◽  
Metalloproteinase 9

Summary: Introduction: Preeclampsia is a life-threatening condition for the mother and foetus. Globally, it is diagnosed in 10 mil. women every year, which accounts for 3% to 8% of all pregnancies. Currently there is no proven effective treatment for preeclampsia. The aforesaid text actualises the issue of predicting this complication. To determine the prognostic significance of matrix metalloproteinases-2 and -9 levels as early markers of preeclampsia, the present prospective study was conducted. Materials and methods: The levels of matrix metalloproteinases-2  and -9  were assessed in 72  patients. Thirty-four  of them subsequently developed preeclampsia during pregnancy (20 patients with moderate preeclampsia, 14 patients with severe preeclampsia), and constituted the basic group; 38 patients made up the control group. Results: In pregnant women with the subsequent development of preeclampsia, the level of matrix metalloproteinase-2 at 11–13 weeks of gestation was 155 ± 73.4 ng/mL and significantly exceeded its level in pregnant women without hypertensive disorders – 75.0 ± 32.8 ng/mL. The study conducted demonstrates a significantly lower concentration of matrix metalloproteinase-9 in pregnant women with preeclampsia compared to the control – 749 ± 296 ng/mL and 1,667 ± 552 ng/mL (P < 0.001). The performed research figures that in the first trimester, the cut-off value of matrix metalloproteinase-2 for predicting the development of preeclampsia is ≥ 102 ng/mL (sensitivity 88.24% and specificity 82.76%). For matrix metalloproteinase-9, a level of ≤ 980 ng/mL in the first trimester predicts the development of preeclampsia with a sensitivity of 85.29% and a specificity of 84.48%. Conclusion: The study established the cut-off values of matrix metalloproteinases-2 and -9 for predicting the development of preeclampsia in the first trimester.

scholarly journals Physical activity during pregnancy and its influence on delivery time: a randomized clinical trial

PeerJ ◽  
2019 ◽  
Vol 7 ◽  
pp. e6370 ◽  
Author(s):  
Raquel Rodríguez-Blanque ◽  
Juan Carlos Sánchez-García ◽  
Antonio Manuel Sánchez-López ◽  
María José Aguilar-Cordero
Keyword(s):  
Physical Exercise ◽  
Pregnant Women ◽  
Intervention Program ◽  
Total Duration ◽  
Perinatal Outcomes ◽  
Exercise Group ◽  
University Hospital ◽  
Control Group ◽  
Beneficial Effects ◽  
The Difference

Introduction During pregnancy, women often change their lifestyle for fear of harmful effects on the child or themselves. In this respect, many women reduce the amount of physical exercise they take, despite its beneficial effects. Objective To determine the duration of labor in pregnant women who completed a program of moderate physical exercise in water and subsequently presented eutocic birth. Methods A randomized trial was performed with 140 healthy pregnant women, divided into an exercise group (EG) (n = 70) and a control group (CG) (n = 70). The women who composed the study population were recruited at 12 weeks of gestation. The intervention program, termed SWEP (Study of Water Exercise during Pregnancy) began in week 20 of gestation and ended in week 37. Perinatal outcomes were determined by examining the corresponding partographs, recorded by the Maternity Service at the Granada University Hospital Complex. Results The intervention phase of the study took place from June through October 2016, with the 120 women finally included in EG and CG (60 in each group). At term, 63% of the women in EG and 56% of those in CG had a eutocic birth. The average total duration of labor was 389.33 ± 216.18 min for the women in EG and 561.30 ± 199.94 min for those in CG, a difference of approximately three hours (p < 0.001). Conclusions The women who exercised in water during their pregnancy presented a shorter duration of labor than those who did not. The difference was especially marked with respect to the duration of the first and second stages of labor.

scholarly journals A study of vascular endothelial growth factor in the cord blood of pre-eclamptics and healthy pregnant women

2017 ◽  
Vol 8 (1) ◽  
pp. 21-25
Author(s):  
Anita Rawat ◽  
Anil Kumar Gangwar ◽  
Archana Ghildiyal ◽  
Neena Srivastava ◽  
Sunita Tiwari ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Cord Blood ◽  
Pregnant Women ◽  
Assay Method ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Vascular Endothelial ◽  
Cord Serum ◽  
Endothelial Growth Factor

Background: Pre-eclampsia(PE) is  the  most  frequently encountered  medical  complication  during  pregnancy. In developing countries PE   is a principal cause of maternal mortality. A disturbance  in  the  angiogenic/antiangiogenic  factors  and  in  the  hypoxia/placental re-oxygenation  process,  seems  to  activate a maternal  endothelial  dysfunction.Aims and Objective: To estimate Vascular Endothelial Growth Factor ( VEGF )  level  in the cord blood of healthy and Preeclamptic ( PEc ) pregnant women and to associate this with Preeclamptic pregnancy.Material and Methods: A case-control study ofUmbilical cord serum VEGF levels from women with uncomplicated pregnancies (control group, n=60) and pregnancies complicated by Pre-eclampsia (n=40). VEGF in the cord serum was estimated by SANDWICH Enzyme Linked Immunosorbent Assay method by using ELISA Kit and then compared between the two groups.Results: The mean VEGF concentrations in the women who had pre-eclampsia  (578.62±468.3)  were lower than in the control group( 625.75±533.1) , but the difference was not statistically significant ( p= 0.8548).  Conclusion VEGF plays a key role in the instability between endothelial dysfunction and angiogenesis that occurs during Preeclampsia.  VEGF levels might be a useful tool for the early diagnosis of Pre-eclampsia.Asian Journal of Medical Sciences Vol.8(1) 2017 21-25

scholarly journals Nutritional Support and Prophylaxis of Azithromycin for Pregnant Women to Improve Birth Outcomes in Peri-Urban Slums of Karachi, Pakistan – A Protocol of Multi-arm Assessor Blinded Randomized Controlled Trial (Mumta PW Trial)

2021 ◽  
Author(s):  
Ameer Muhammad ◽  
Zoha Zahid Fazal ◽  
Benazir Baloch ◽  
Imran Nisar ◽  
Fyezah Jehan ◽  
...  
Keyword(s):  
Informed Consent ◽  
Pregnant Women ◽  
Low Income ◽  
Controlled Trial ◽  
Perinatal Outcomes ◽  
Urban Slum ◽  
Control Group ◽  
Maternal Undernutrition ◽  
Randomized Controlled ◽  
Group 2

Abstract BackgroundMaternal undernutrition is critical in the etiology of poor perinatal outcomes and accounts for 20% of small-for-gestational-age (SGA) births. High levels of food insecurity, antenatal undernourishment and childhood undernutrition necessitate the supplementation of fortified balanced energy-protein (BEP) during pregnancy in low-income settings especially with scarce literature available in this subject. Hence, this paper extensively covers the protocol of such a trial conducted in an urban slum of Karachi, Pakistan. Methods The trial is community-based, open-labelled, four-arm, and randomized controlled that will include parallel group assignments with a 1:1:1:1 allocation ratio in low-income squatter settlements in urban Karachi, Pakistan. All pregnant women (PW), if identified between > 8 and <19 weeks of gestation based on ultrasound, will be offered routine antenatal care (ANC) counseling and voluntary participation in the trial after written informed consent. A total number of 1836 PW will be enrolled with informed consent and randomly allocated to one of the four arms receiving: (1) ANC counseling only (control group), (2) ANC counseling plus BEP supplement (intervention arm 1), (3) ANC counseling plus BEP supplement plus 2 doses Azithromycin (intervention arm 2), or (4) ANC counseling plus BEP supplement plus daily single dose of Nicotinamide and Choline (intervention arm 3). Trial Registration ClinicalTrials.gov NCT04012177. Registered on July 9, 2019. (https://clinicaltrials.gov/ct2/show/NCT04012177)

scholarly journals Influence of active and passive smoking at pregnancy on expression of an oxidizing stress

2019 ◽  
pp. 236-239
Author(s):  
O. A. Chursina ◽  
O. D. Konstantinova ◽  
S. I. Krasikov ◽  
A. A. Petrova ◽  
N. I. Kolosova
Keyword(s):  
Blood Serum ◽  
Pregnant Women ◽  
Passive Smoking ◽  
Rapid Test ◽  
Superoxide Dismutases ◽  
Control Group ◽  
Active Smoking ◽  
Smoking During Pregnancy ◽  
Definition Of

Objective: definition of indicators of system prooksidanty-antioxidants at active and passive smoking during pregnancy. Material and methods. On the basis of city clinic for women 39 pregnant women on the term of a gestation of 37 weeks are examined. Questioning, rapid test for identification of a kotinin in urine, determination of level of a malon dialdehyde (MDA) and also activities superoxide dismutases (SOD) and catalases is carried out to bloods of surveyed. Patients are divided into 3 groups: I-of 11 smoking pregnant women subject to II-13 to passive smoking at pregnancy, III-control group of 15 women. Results. At patients of I and II groups substantial increase of level MDA in blood serum is noted. Reliable decrease of the activity of SOD of erythrocytes in the I group and insignificant decrease of the activity in II is taped. The indicator of catalase/SOD was statistically higher at active smoking. Conclusion. Active and passive smoking at pregnancy leads to change in prooxidatic and antioxidatic systems.

Sign in / Sign up

Export Citation Format

Share Document